{"id":"W4415939211","doi":"10.1016/j.ejca.2025.116093","title":"Paediatric Strategy Forum for medicinal product development of agents targeting GD2 ganglioside in children and adolescents with cancer","year":2025,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"U.S. Food and Drug Administration; Andrew McDonough B+ Foundation","keywords":"Neuroblastoma; Chimeric antigen receptor; Monoclonal antibody; Cancer; Ganglioside; Antibody; Antibody therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005820785,0.0003326085,0.001242686,0.000574522,0.00005070292,0.00001597632,0.0001876954,0.00003281017,0.00002250497],"category_scores_gemma":[0.0001243725,0.0002080565,0.00016424,0.0004158732,0.00005591714,0.0000670058,0.00006975383,0.0004729681,0.000001085844],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002340038,"about_ca_system_score_gemma":0.002404823,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001573944,"about_ca_topic_score_gemma":0.00002991709,"domain_scores_codex":[0.9975491,0.0002301517,0.0009899316,0.0003083971,0.0005348633,0.0003875506],"domain_scores_gemma":[0.9984171,0.00003882018,0.0008715588,0.0001337872,0.0003099134,0.0002287968],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003715355,0.0001501358,0.01386127,0.01214278,0.0006763308,0.0003030604,0.00005671307,0.000004110875,0.000003805491,2.561995e-7,0.001560172,0.9708698],"study_design_scores_gemma":[0.0219055,0.00369623,0.1794233,0.3907909,0.006393307,0.0008518826,0.0001069922,0.000003542991,0.0003621443,0.000003681902,0.3955612,0.0009013417],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003889488,0.9944983,0.00001976096,0.00007466087,0.0001312175,0.001246943,0.00004872126,0.000004496423,0.0000864211],"genre_scores_gemma":[0.01904515,0.9797316,0.0004386393,0.00004034736,0.0003848533,0.00003646456,0.00001601197,0.00006452794,0.0002424215],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9699685,"threshold_uncertainty_score":0.8484297,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02764842018913576,"score_gpt":0.3479686014046495,"score_spread":0.3203201812155138,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}